Conveners
Isotope Production, Target and Ion Sources II
- Luca Egoriti (TRIUMF)
TATTOOS (Targeted Alpha Tumor Therapy and Other Oncological Solutions) offers the potential to produce radionuclidically pure radioisotopes towards radiopharmaceutical applications, revolutionizing cancer diagnosis and treatment. The facility plans to utilize a portion (100 μA) of the high-intensity (~2.4 mA), high-energy (590 MeV) proton beam from the ring cyclotron at Paul Scherrer...
With multiple planned online target stations and offline test stands, TRIUMF is establishing a unique facility for the production of radioactive ion beams (RIBs). This multi-station configuration, centered around the ARIEL project, creates unique opportunities for systematic R&D on ISOL targets, ion sources, and associated technologies. The magnitude of the project presents commissioning...
Isotope Separation Online (ISOL) facilities generate purified radioactive isotope beams for research in fundamental nuclear and atomic physics, condensed-matter, biology and medical applications. As part of the first phase of the MYRRHA program at SCK CEN, a new ISOL facility is being developed, ISOL@MYRRHA, featuring a high-power 100-MeV proton beam with currents up to 500 μA. This will...